Today’s AI Top Pick: PODD
7/31/2026 · Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live PODD price forecast →
Insulet (PODD) is the cleanest 'strong fundamentals + confirming tape + no bad news' combination in the pool. It carries a top-tier fundamental_score of 8 with fwdPE 20.57, PEG 0.77, ROE 23%, profit margin 10.4% and – critically – salesYoY of 31.9% (best growth among the large-cap medical names here). Analyst recom of 1.54 with 40.2% target upside gives it real Street support, and there is nothing negative in the recent headline block – just a Q2 earnings preview and 'quality affordable growth' write-ups. The forecast tape is the tightest multi-timeframe alignment in the list. 1h fc +8.89/+8.00/+12.24, 4h +20.88/+50.53/+53.49, 1d +15.48/+36.87/+64.16, 1wk +8.05/+27.10/+39.73 – every single horizon on every single timeframe is positive and expanding into mid/long. bullish_prob 1.0 and near_term_bullish 1.0 both confirm. Crucially, you are NOT chasing. Price 164.66 sits at only pos_in_21bar_range_pct 22.3% (1h), 54.7% (1d) and 24% (1wk), with a weekly drawdown of -27.5% from the 21-bar high and a YTD perf of -41.7%. This is a stock that has already been punished, is basing, and now has the forecast models turning aggressively higher – the opposite of a top-of-range breakout trap you see in FUTU, PDD or MNSO where 1wk long-term forecasts are already fading or price sits at 90%+ of range. Why TODAY: 1h drawdown is only -5.9% and 4h/1d forecasts are pointing to +20-50% moves within the mid horizon, so waiting for a deeper pullback risks missing the ramp. The Q2 print on Aug 25 is the near-term catalyst window, and entering ahead of a raised bar with sales growth accelerating >30% is the highest-Sharpe setup in the pool. Compare to FICO (guidance cut, worst day in a year – disqualified), NOW (layoffs, 1h forecasts negative), FUTU (SFC/DOJ overhang), and TCOM (anti-monopoly fine overhang) – PODD has no landmines.

- Q2 earnings on Aug 25 – a guide-down would break the setup; size accordingly ahead of print
- Short float 6.74% is not huge but can amplify moves against a miss
- Debt/Eq 0.73 with only 10.4% profit margin leaves less cushion than software peers
- 1wk drawdown of -27.5% and perfYear -44.4% mean the trend is technically still down – this is a reversal trade, not a trend continuation
- Sector rotation risk: MedTech has been out of favor; a broad tape drop (like the Dow's worst day in a year noted 7/29) would drag PODD regardless of company-specific setup
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | PODD | BUY NOW | 8.8 | All four TFs positive, not extended (1h pos 22%, DD -27.5% wk), 31.9% sales growth, clean news – tightest setup in the pool. |
| 2 | PDD | BUY NOW | 8.3 | Cheap (fwdPE 7.06), all TFs positive with 1wk fc_long +34.1%, but pos 90% on daily = slight chase. |
| 3 | INTU | BUY NOW | 8.1 | Huge 1d/1wk mid-long forecasts (+48/+96, +47/+76) off deep -31% weekly DD, dual catalysts Aug 25 + Sep 17. |
| 4 | MNSO | BUY NOW | 7.9 | PEG 0.17 with 30.5% sales growth, forecasts +30-47% across mid-TFs, but 1wk fc_short only +0.55% and Seeking Alpha downgrade. |
| 5 | TMUS | BUY NOW | 7.6 | Bottom-of-range (pos 0-9%), -20% weekly DD, all near-term forecasts +9-20%; weekly long-term slightly negative caps upside. |
| 6 | TMDX | BUY NOW | 7.4 | 1d fc_mid +51.6%, ROE 45%, profit margin 27%; short float 23.2% and pos 94% on daily = higher volatility risk. |
| 7 | TCOM | BUY PULLBACK | 7.1 | Cheapest large-cap here (PE 7.32), profit margin 48%, but 1h forecasts negative and antitrust fine overhang from JPM downgrade. |
| 8 | ACM | BUY NOW | 7.0 | Positive catalyst (Lisbon airport win), 1d forecasts +23-37%, but only 7.7% gross margin and negative sales YoY. |
| 9 | BILI | BUY NOW | 6.9 | Multi-TF positive with 1wk DD -25%, ad monetization narrative, but PE 42.7 and low margins (4.6%). |
| 10 | WAY | BUY NOW | 6.8 | 1d fc_mid +49.9%, three analyst Buy reiterations, but PTs were lowered to $33 – capped upside. |
| 11 | ADSK | BUY NOW | 6.7 | ROE 50%, all TFs positive with 1wk fc_long +20.5%, but modest magnitude vs pool. |
| 12 | TIGR | BUY NOW | 6.6 | Big forecasts (+68/+79 mid-long) off -33% weekly DD, 48% sales growth, but low mkt cap ($885M) volatility. |
| 13 | TRMB | BUY NOW | 6.4 | Analysts target +54%, all TFs positive, but weak salesYoY 3.25% and 1h forecast tepid. |
| 14 | NRDS | BUY NOW | 6.3 | PEG 0.26, 4h/1d/1wk positive but 1h -7% DD, low mkt cap. |
| 15 | FINV | BUY NOW | 6.2 | PE 4.15, recom 1.0, 1wk fc_long +17%, but tiny sales growth 0.84%. |
| 16 | MLCO | BUY NOW | 6.0 | PEG 0.37, 1wk fc_long +42.7%, but near_term_bullish only 0.4 and 1h forecasts negative. |
| 17 | BR | BUY PULLBACK | 5.9 | ROE 42%, 1d fc_long +39.6%, but 1h/1wk short-term forecasts negative and Jensen trimmed. |
| 18 | PTC | BUY PULLBACK | 5.6 | Just reported Q3 miss on E&S but raised ARR view; Stifel lowered PT – wait for post-print digestion. |
| 19 | FIGR | BUY PULLBACK | 5.4 | PEG 0.48, target upside 92%, but bullish_prob null and 1d DD -24% – base still forming. |
| 20 | CRM | BUY PULLBACK | 5.3 | 1d fc_long +29%, but near_term_bullish 0 and 1h -5% DD; AI monetization skepticism in headlines. |
| 21 | FUTU | WAIT | 5.2 | Huge 4h/1d forecasts but SFC HK$125M asset freeze and prior DOJ probe headlines create binary regulatory risk. |
| 22 | QTWO | WAIT | 5.0 | bullish_prob 0.4 (below threshold), 1h forecast -23.4%, RSI 66.5 already stretched. |
| 23 | SE | WAIT | 4.7 | 1h/4h forecasts -12% and near_term_bullish 0.2 – tape rolling over despite bullish_prob 1. |
| 24 | ADBE | WAIT | 4.5 | Target upside only 2%, recom 2.65 (weak), currently declining with market weakness. |
| 25 | SPRO | AVOID | 4.2 | 1wk forecasts all negative (-20 to -30%), RSI 22, small cap $69M – broken chart despite optical fundamentals. |
| 26 | FRSH | AVOID | 3.9 | bullish_prob 0, all forecast horizons negative (-3 to -22%), pos 100% on weekly = classic top. |
| 27 | NOW | AVOID | 3.5 | Announced ~1K layoffs, 1h forecasts -12%, near_term_bullish 0 – rightsizing narrative caps upside. |
| 28 | PFSI | AVOID | 3.0 | Piper downgrade, Stephens PT cut to $78, RSI 34 – active deterioration. |
| 29 | KMPR | AVOID | 2.8 | Auto leadership exit, StockStory '3 reasons to sell', ROE 1.5%, profit margin 0.89% – broken. |
| 30 | FICO | AVOID | 2.5 | Worst day in 6 years on downside guidance – thesis just broken; do not catch this knife. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord